All posts

IPO Supply Is Quiet, but Market Plumbing Is Getting Louder

New listings, secondary supply, buybacks, lockups and Reg NMS changes are reshaping the liquidity test for public markets.

Times Square in New York City, a hub for public-market listings and financial activity
Photo by Sasha Zilov on PexelsPhoto by Vlada Karpovich on Pexels

IPO Supply Is Quiet, but Market Plumbing Is Getting Louder

The public-markets signal in late August is not simply that IPOs are “back.” It is that the balance between new supply and available liquidity is becoming more important than the headline count of deals.

The near-term U.S. calendar is unusually light: Renaissance Capital’s week-ahead review said only one company was set to list in the week of August 24, with Japanese fintech Advasa Holdings scheduled for a Nasdaq direct listing. Yet its IPO basket was up 18.6% year to date through August 20, versus 12.5% for the S&P 500.[1] That combination—strong performance in the cohort, limited immediate supply—is constructive for sentiment, but it is not the same thing as broad, durable market depth.

Times Square in New York City, a hub for public-market listings and financial activity

The lead signal: performance is ahead of issuance

A thin calendar can support existing new listings by reducing the number of deals competing for investors’ attention and risk capacity. The counterpoint is that a quiet week tells us little about the pipeline’s ability to absorb larger offerings once issuers return in size.

Renaissance Capital reported that six companies were due to receive Street research in the week ahead and that one lock-up period was expiring.[1] Those are small calendar details with larger implications: research coverage can broaden participation, while a lockup expiry can increase the freely tradable supply without a new primary deal.

The base-rate question is therefore straightforward: are newly public companies outperforming because their businesses are being repriced upward, or because scarce float is meeting concentrated demand? The evidence supports keeping both explanations open.

Secondary offerings add supply without adding a new issuer

The market’s supply picture is broader than the IPO calendar. Recent examples include:

  • BridgeBio Pharma announced an oversubscribed secondary offering intended to diversify its institutional shareholder base.[2]
  • OPENLANE priced a registered offering of 8 million shares by a selling stockholder, alongside a concurrent share repurchase.[2]
  • Alliance Laundry announced pricing of an upsized public offering by a selling stockholder.[2]

These transactions matter because “issuance” can mean two different things. A primary offering raises capital for the company and increases shares outstanding; a secondary offering mainly changes who owns already-issued shares. Both can increase the stock available to public investors, but their effects on dilution, cash balances and shareholder composition are different.

That distinction is useful when reading the tape. A stock that weakens around a secondary may be responding to a larger float, a discount, an overhang from a large holder, or simply the information that an early investor wants liquidity. The headline deal size alone does not identify which mechanism dominates.

Buybacks are the offsetting flow

On the other side of the ledger, companies continue to announce repurchase capacity. MetLife approved a new $3 billion authorization on August 5, incremental to roughly $400 million remaining under its prior authorization.[3] Globe Life announced a $2.5 billion authorization effective August 15.[3] Curtiss-Wright said an additional $100 million expansion brought expected 2026 repurchases to $260 million.[3]

Repurchase authorizations are not the same as completed purchases, and they do not automatically neutralize new supply. Timing, blackout periods, prices, cash generation and management’s willingness to execute all matter. Still, the coexistence of buybacks and equity offerings creates a more nuanced liquidity map than a simple “more shares” or “fewer shares” narrative.

Flow Immediate market effect to assess What it does not tell you by itself
Primary IPO Adds a new issuer and generally new shares Whether demand will persist after the first sessions
Secondary offering Increases public float or changes ownership Whether the company receives new capital
Lockup expiry Makes previously restricted shares eligible for sale Whether holders will actually sell
Buyback authorization Creates potential corporate demand How much will be executed, and when
Direct listing Opens trading without a conventional underwritten IPO structure Whether liquidity will be deep from day one

Lockups are a liquidity event, not just a date

The most visible recent example is SpaceX. CNBC reported that the first post-IPO lockup period made 911 million shares eligible for trading on August 6.[4] That is a meaningful test of how a market handles a large increase in potential float.

The important variable is not merely the number of shares unlocked. It is the gap between shares eligible to sell and shares actually offered, plus the depth of bids willing to absorb them. A lockup can pass quietly if holders retain stock and demand is broad; it can create volatility if several holders seek liquidity at once or if investors anticipate that possibility.

For any newly listed company, the practical checklist is:

  • Identify the number of shares becoming eligible, not just the expiry date.
  • Separate employee, founder, sponsor and financial-investor restrictions where filings provide that detail.
  • Compare average daily volume with the potential newly tradable supply.
  • Track whether the issuer, a selling holder or both are raising cash.
  • Watch spreads and intraday depth, not only the closing price.

Regulation NMS could change the plumbing beneath the flows

The SEC proposed rescinding Regulation NMS Rules 611 and 610(e) in June. The proposal would remove the trade-through prohibition for national market system stocks and restrictions on locking and crossing quotations; the comment period was set to remain open for 60 days after publication in the Federal Register.[5]

This is a proposal, not a completed rule change. But it is consequential because market structure influences how efficiently new supply is distributed across venues. The SEC’s stated rationale is to simplify the framework, reduce costs and allow competition and innovation to shape equity markets.[5] The counter-question for investors and issuers is whether changes in routing protections and quotation behavior improve displayed liquidity, fragment it, or shift liquidity toward venues and participants that are harder to observe from the consolidated tape.

This matters most when markets are stressed. A highly liquid stock in calm conditions can look robust even if displayed depth disappears quickly during a sudden wave of selling. The durability of liquidity—not its average appearance—is the market-structure test.

New York Stock Exchange architectural reliefs representing the exchange infrastructure behind public-market trading

What to watch next

  1. The next meaningful IPO cluster. Compare the number and size of deals that actually price with the number filed or marketed. The late-August calendar alone is not a verdict on the pipeline.
  2. ADBT’s direct-listing mechanics. Advasa Holdings is scheduled to complete a Nasdaq direct listing; its opening liquidity and early turnover can offer a useful contrast with a conventional underwritten IPO.[1]
  3. Secondary supply versus buyback execution. Track completed repurchases where disclosed, not just authorizations, and distinguish selling-holder transactions from primary capital raises.
  4. Lockup absorption. For large recent listings, compare newly eligible shares with volume, spreads and price behavior over several sessions rather than treating the expiry as a one-day event.
  5. The Reg NMS process. Watch the SEC proposal’s comment record, any revised text and the implementation path. Until then, treat the market-structure implications as scenarios rather than settled outcomes.

The durable takeaway is balanced: newly public equities are showing relative strength, but the supply regime is still being tested. IPOs, secondaries, lockups and buybacks each alter the float in different ways, while exchange rules determine how that float is matched. A healthy issuance market is therefore not just one that can bring companies public; it is one that can distribute risk without liquidity vanishing when the flow turns one-sided.

Sources

  1. IPO News - US IPO Week Ahead: August IPO market set to wrap up with a quiet weekrenaissancecapital.com
  2. BridgeBio Pharma Inc. - BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Of…investor.bridgebio.com
  3. SpaceX faces test as shares unlock allowing early investors cash outcnbc.com
  4. IPO News - US IPO Week Ahead: August IPO market set to wrap up with a quiet weekrenaissancecapital.com
  5. SEC.gov | SEC Proposes Rescission of Regulation NMS Rules 611 and 610(e)sec.gov